Digoxin bioequivalence study: Determination in human plasma by microparticle enzyme immunoassay

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 6, 2007, Pages 366-372

  do Carmo Borges, N Carter ^a,b,c   Guermani, A ^a   Mazucheli, J A ^a   Duarte Mendes, G ^b   Moreno, R A ^a,b  

^a Synchrophar Pesquisas Clínicas   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c NONE   (Brazil)

Author keywords

Bioequivalence; Digoxin; Microparticle enzyme immunoassays; Pharmacokinetic

Indexed keywords

ALKALINE PHOSPHATASE; DIGOX; DIGOXIN; HYMECROMONE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; FEMALE; FLUORESCENCE ANALYSIS; FOOD AND DRUG ADMINISTRATION; GEOMETRY; HUMAN; HUMAN EXPERIMENT; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; NORMAL HUMAN; OPEN STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; TABLET; VOLUNTEER;

EID: 34250181363     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/cpp45366     Document Type: Article

References (21)

1. Aboul-Enein HY, Abou-Basha LL, Wahman LF. Comparative bioavailability study of two tablet formulations of digoxin. J Immunoassay Immunochem. 2004; 25: 125-133.
2. Cheymol G, Jaillon P. Heteroside Cardiotonique. Sem Hop Paris. 1985; 61: 841-873.
3. Eichhorst O, Hinderling PH. Specific assay for radio-labelled digoxin and its known apolar metabolites in biological fluids. J Chromatogr. 1981; 224: 67-93.
4. Food and Drug Administration. In vivo bioequivalence guidances. Pharmacopeial Forum. 1993; 19: 6501-6508.
5. Food and Drug Administration. Bioavailability and bioequivalence requirements; abbreviated applications; proposed revisions. Pharmacopeial Forum. 1998; 63: 64222-64228.
6. Graves SW, Brown B, Valdes R Jr. An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med. 1983; 99: 604-608.
7. Guan F, Ishii A, Seno H, Suzuki KW, Kumazawa T, Suzuki O. Identification and quantification of cardiac glycosides in blood and urine samples by HPLC/MS/MS. Anal Chemistry. 1999; 71: 4034-4043.
8. Ijiri Y, Hayashi T, Ogihara T, Ohi K, Suzuki K, Tamai H, Kitaura Y, Takenaka H, Tanaka K. Increased digitalis-like immunoreactive substances in neonatal plasma measured using fluorescence polarization immunoassay. J Clin Pharmacol and Ther. 2004; 29: 565-571.
9. Kwong E, McErlane KM. Development of a high-performance liquid chromatography assay for digoxin using post-column fluorogenic derivatization. J Chromatogr. 1986; 377: 233-242.
10. Mant T, Fournié P, Ollier C, Donat F, Necciari J. Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers. Clin Pharmacokinet. 2002; 2: 39-45.
11. Nelson HA, Lucas SV, Gibson TP. Isolation by high-performance liquid chromatography and quantification by radioimmunoassay of therapeutic concentrations of digoxin and metabolites. J Chromatogr. 1979; 163: 169-177.
12. Pähkla R, Irs A, Oselin K, Rootslane L. Digoxin: use pattern in Estonia and bioavailability of the local market leader. J Clin Pharmacol and Ther. 1999; 24: 375-380.
13. Pudek MR, Seccombe DW, Whitfied MF, Ling E. Digoxin-like immunoreactive in premature and full-term infants not receiving digoxin therapy. N Engl J Med. 1983; 308: 904-905.
14. Quazzaz HMAM, Goudy S, Miller JJ, Valdes R. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor. Therapeutic Drug Monitoring. 1995; 17: 53-59.
15. Radembino N, Poirier JM, Ragueneau I, Jaillon P. Improved sensitivity of digoxin assay by modification of the EMIT 2000 method. Ther Drug Monit. 1999; 21: 256-258.
16. Ragueneau I, Poirier JM, Radembino N, Sao AB, Funck-Bretano C, Jaillon P. Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers. Br J Clin Pharmacol. 1999; 48: 453-456.
17. Reynolds JEF. Martindale: The Extra Pharmacopeia. 29th ed. 1989; 29: 822.
18. Rodin SM, Johnson BF. Pharmacokinetic interactions with digoxin. Clin Pharmacokinet. 1988; 15: 227-244.
19. Smith TE, Haber E. Digitalis III. N Engl J Med. 1973; 289: 1063-1067.
20. Tracqui A, Kintz P, Ludes B, Mangin P. High-performance liquid chromatography-ionspray mass spectrometry for the specific determination of digoxin and some related cardiac glycosides in human plasma. J Chromatogr B. 1997; 692: 101-109.
21. Watson E, Tramell P, Kalman SM. Identification of submicrogram amounts of digoxin, digitoxin, and their metabolic products isolation by chromatography and preparation of derivatives for assay by electron capture detector. J Chromatogr. 1972; 69: 157-163.